These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 8066070

  • 21. p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.
    Done SJ, Arneson NC, Ozçelik H, Redston M, Andrulis IL.
    Cancer Res; 1998 Feb 15; 58(4):785-9. PubMed ID: 9485035
    [Abstract] [Full Text] [Related]

  • 22. p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer.
    Elledge RM, Clark GM, Fuqua SA, Yu YY, Allred DC.
    Cancer Res; 1994 Jul 15; 54(14):3752-7. PubMed ID: 8033095
    [Abstract] [Full Text] [Related]

  • 23. The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer.
    Kang JH, Kim SJ, Noh DY, Choe KJ, Lee ES, Kang HS.
    J Mol Med (Berl); 2001 Nov 15; 79(11):648-55. PubMed ID: 11715068
    [Abstract] [Full Text] [Related]

  • 24. Prognostic value of p53 protein expression in breast carcinomas.
    Hurlimann J.
    Pathol Res Pract; 1993 Nov 15; 189(9):996-1003. PubMed ID: 8302733
    [Abstract] [Full Text] [Related]

  • 25. Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.
    Thorlacius S, Börresen AL, Eyfjörd JE.
    Cancer Res; 1993 Apr 01; 53(7):1637-41. PubMed ID: 8453635
    [Abstract] [Full Text] [Related]

  • 26. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC, Chen CY, Chen SK, Cherng SH, Ho WL, Lee H.
    Cancer Res; 1998 Jan 15; 58(2):328-33. PubMed ID: 9443413
    [Abstract] [Full Text] [Related]

  • 27. Discordance of p53 mutations of synchronous colorectal carcinomas.
    Eguchi K, Yao T, Konomoto T, Hayashi K, Fujishima M, Tsuneyoshi M.
    Mod Pathol; 2000 Feb 15; 13(2):131-9. PubMed ID: 10697269
    [Abstract] [Full Text] [Related]

  • 28. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M.
    Oncogene; 1998 May 14; 16(19):2469-77. PubMed ID: 9627113
    [Abstract] [Full Text] [Related]

  • 29. Possible association of p53 overexpression and mutation with high-grade chondrosarcoma.
    Dobashi Y, Sugimura H, Sato A, Hirabayashi T, Kanda H, Kitagawa T, Kawaguchi N, Imamura T, Machinami R.
    Diagn Mol Pathol; 1993 Dec 14; 2(4):257-63. PubMed ID: 8118603
    [Abstract] [Full Text] [Related]

  • 30. p53 gene alterations in special types of breast carcinoma: a molecular and immunohistochemical study in archival material.
    Karameris AM, Worthy E, Gorgoulis VG, Quezado M, Anastassiades OT.
    J Pathol; 1995 Aug 14; 176(4):361-72. PubMed ID: 7562251
    [Abstract] [Full Text] [Related]

  • 31. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
    Guo LL, Gao P, Wu YG, Jian WC, Hao CY, Li H, Lin XY.
    Arch Med Res; 2007 Nov 14; 38(8):846-52. PubMed ID: 17923265
    [Abstract] [Full Text] [Related]

  • 32. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS, Lin SR, Chang MY, Chen FM, Lu CY, Huang TJ, Huang YS, Huang CJ, Wang JY.
    Am Surg; 2005 Apr 14; 71(4):336-43. PubMed ID: 15943410
    [Abstract] [Full Text] [Related]

  • 33. Loss of heterozygosity and p53 gene mutations in breast cancer.
    Deng G, Chen LC, Schott DR, Thor A, Bhargava V, Ljung BM, Chew K, Smith HS.
    Cancer Res; 1994 Jan 15; 54(2):499-505. PubMed ID: 8275488
    [Abstract] [Full Text] [Related]

  • 34. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
    Hashimoto T, Tokuchi Y, Hayashi M, Kobayashi Y, Nishida K, Hayashi S, Ishikawa Y, Tsuchiya S, Nakagawa K, Hayashi J, Tsuchiya E.
    Cancer Res; 1999 Nov 01; 59(21):5572-7. PubMed ID: 10554037
    [Abstract] [Full Text] [Related]

  • 35. p53 alterations are associated with improved prognosis in distal colonic carcinomas.
    Soong R, Grieu F, Robbins P, Dix B, Chen D, Parsons R, House A, Iacopetta B.
    Clin Cancer Res; 1997 Aug 01; 3(8):1405-11. PubMed ID: 9815825
    [Abstract] [Full Text] [Related]

  • 36. Comparison of P53 protein overexpression with P53 mutation in bladder cancer: clinical and biologic aspects.
    Vet JA, Bringuier PP, Schaafsma HE, Witjes JA, Debruyne FM, Schalken JA.
    Lab Invest; 1995 Dec 01; 73(6):837-43. PubMed ID: 8558845
    [Abstract] [Full Text] [Related]

  • 37. P53 in breast carcinomas: association between presence of mutation and immunohistochemical expression using a semiquantitative approach.
    Schmitt FC, Soares R, Cirnes L, Seruca R.
    Pathol Res Pract; 1998 Dec 01; 194(12):815-9. PubMed ID: 9894246
    [Abstract] [Full Text] [Related]

  • 38. Detection of loss of heterozygosity of p53 gene in paraffin-embedded breast cancers by non-isotopic PCR-SSCP.
    Chen YH, Li CD, Yap EP, McGee JO.
    J Pathol; 1995 Oct 01; 177(2):129-34. PubMed ID: 7490678
    [Abstract] [Full Text] [Related]

  • 39. A study of stabilisation of p53 protein versus point mutation in colorectal carcinoma.
    Cripps KJ, Purdie CA, Carder PJ, White S, Komine K, Bird CC, Wyllie AH.
    Oncogene; 1994 Sep 01; 9(9):2739-43. PubMed ID: 8058340
    [Abstract] [Full Text] [Related]

  • 40. p53 alterations in uterine leiomyosarcomas versus leiomyomas.
    de Vos S, Wilczynski SP, Fleischhacker M, Koeffler P.
    Gynecol Oncol; 1994 Aug 01; 54(2):205-8. PubMed ID: 8063247
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.